Recent advancements in corpus luteum development, function, maintenance and regression: Forum introduction

por Davis, John S, Rueda, Bo R
Publicado 2003

No REST for fibroids

por Rueda, Bo R., Davis, John S.
Publicado 2013

Stem Cell Contribution to Ovarian Development, Function, and Disease

por Tilly, Jonathan L., Rueda, Bo R.
Publicado 2008

Microvascular endothelial cells of the corpus luteum

por Spanel-Borowski Katherina, Rueda Bo R, Davis John S
Publicado 2003-11-01

Mutant mouse models and their contribution to our knowledge of corpus luteum development, function and regression

por Henkes, Luiz E, Davis, John S, Rueda, Bo R
Publicado 2003

Microvascular endothelial cells of the corpus luteum

por Davis, John S, Rueda, Bo R, Spanel-Borowski, Katherina
Publicado 2003

The Current Status of Evidence for and Against Postnatal Oogenesis in Mammals: A Case of Ovarian Optimism Versus Pessimism?

por Tilly, Jonathan L., Niikura, Yuichi, Rueda, Bo R.
Publicado 2009

Ovarian Cancer Stem Cell Markers: Prognostic and Therapeutic Implications

por Burgos-Ojeda, Daniela, Rueda, Bo R., Buckanovich, Ronald J.
Publicado en Cancer Lett (2012)

Cables1 protects p63 from proteasomal degradation to ensure deletion of cells after genotoxic stress

por Wang, Ning, Guo, Lankai, Rueda, Bo R, Tilly, Jonathan L
Publicado 2010

Signaling mechanisms in tumor necrosis factor alpha-induced death of microvascular endothelial cells of the corpus luteum

por Pru, James K, Lynch, Maureen P, Davis, John S, Rueda, Bo R
Publicado 2003

The Therapeutic Challenge of Targeting HER2 in Endometrial Cancer

por J. Diver, Elisabeth, Foster, Rosemary, Rueda, Bo R., Growdon, Whitfield B.
Publicado en Oncologist (2015)

Influence of a novel histone deacetylase inhibitor panobinostat (LBH589) on the growth of ovarian cancer

por Garrett, Leslie A., Growdon, Whitfield B., Rueda, Bo R., Foster, Rosemary
Publicado en J Ovarian Res (2016)

MicroRNA-15b regulates reversion-inducing cysteine-rich protein with Kazal motifs (RECK) expression in human uterine leiomyoma

por Guan, Yichun, Guo, Lankai, Zukerberg, Lawrence, Rueda, Bo R., Styer, Aaron K.
Publicado en Reprod Biol Endocrinol (2016)

Longitudinal expression of Toll-like receptors on dendritic cells in uncomplicated pregnancy and postpartum

por Young, Brett C., Stanic, Aleksandar K., Panda, Britta, Rueda, Bo R., Panda, Alexander
Publicado en Am J Obstet Gynecol (2013)

Endometrial cancer is a receptor-mediated target for Mullerian Inhibiting Substance

por Renaud, Elizabeth J., MacLaughlin, David T., Oliva, Esther, Rueda, Bo R., Donahoe, Patricia K.
Publicado 2005

Notch signaling in serous ovarian cancer

por Groeneweg, Jolijn W, Foster, Rosemary, Growdon, Whitfield B, Verheijen, René HM, Rueda, Bo R
Publicado en J Ovarian Res (2014)

The impact of vitrification on murine germinal vesicle oocyte In vitro maturation and aurora kinase A protein expression

por Doyle, Joseph O., Lee, Ho Joon, Selesniemi, Kaisa, Styer, Aaron K., Rueda, Bo R.
Publicado en J Assist Reprod Genet (2014)

Inhibition of AKT with the Orally Active Allosteric AKT Inhibitor, MK-2206, Sensitizes Endometrial Cancer Cells to Progestin

por Pant, Alok, Lee, Irene I., Lu, Zhenxiao, Rueda, Bo R., Schink, Julian, Kim, J. Julie
Publicado 2012

Understanding and Targeting Apoptotic Pathways in Ovarian Cancer

por Al-Alem, Linah F., Baker, Andrew T., Pandya, Unnati M., Eisenhauer, Eric L., Rueda, Bo R.
Publicado en Cancers (Basel) (2019)

Galectins and Ovarian Cancer

por Shimada, Chisa, Xu, Rui, Al-Alem, Linah, Stasenko, Marina, Spriggs, David R., Rueda, Bo R.
Publicado en Cancers (Basel) (2020)